Over the past year, 23andMe set new corporate governance lows. CEO Anne Wojcicki now enters de facto “founder mode” after a ...

The blue-chip board and the startup star had been on a collision course for months. Here’s what really happened.

With 23andme in a desperate situation and eyeing a potential sale, Medical Device Network examines what is set to happen to ...

Me helped usher in the era of consumer DNA test kits nearly two decades ago, but has more recently faced a series of setbacks ...

Consumer DNA testing company 23andMe is circling the drain. The company's CEO, Anne Wojcicki, plans to take the company ...

The entire board of DNA testing company 23andMe resigned after a conflict with CEO Anne Wojcicki over her plan to take the ...

23andMe, named because of the number of chromosome pairs in human DNA, raised more than $1.1bn before its hotly awaited IPO ...

Turmoil at 23andMe, and a lawsuit alleging that GEDmatch shares data with Facebook, highlights how far your genetic ...

A giant biotechnology company might be about to go bust. What will happen to the millions of people’s DNA it holds?

Financial and security chaos at the once-pioneering genetic testing firm has intensified concerns about user data. Here's how ...

Anne Wojcicki, CEO of 23andMe, the struggling DNA testing company, doesn’t think this is the right time to examine her ...

In 2009, Anne Wojcicki took a decisive step in her role as the leader of 23andMe, the genetic testing company she co-founded ...